IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

PERROTTA, Fabio Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.289
NA - Nord America 2.215
AS - Asia 601
AF - Africa 278
SA - Sud America 36
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 5.439
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.177
IE - Irlanda 770
SG - Singapore 314
CI - Costa d'Avorio 270
IT - Italia 231
RU - Federazione Russa 197
AT - Austria 194
FI - Finlandia 180
UA - Ucraina 160
CN - Cina 155
DE - Germania 154
GB - Regno Unito 89
FR - Francia 85
SE - Svezia 79
HK - Hong Kong 59
PL - Polonia 53
CA - Canada 31
BE - Belgio 30
IN - India 23
BR - Brasile 22
NL - Olanda 18
LT - Lituania 14
AU - Australia 11
EU - Europa 8
TR - Turchia 7
CL - Cile 6
IR - Iran 6
CO - Colombia 5
CH - Svizzera 4
EG - Egitto 4
ES - Italia 4
MX - Messico 4
TH - Thailandia 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
IL - Israele 3
JP - Giappone 3
LV - Lettonia 3
MY - Malesia 3
PT - Portogallo 3
VN - Vietnam 3
CY - Cipro 2
GR - Grecia 2
ID - Indonesia 2
KG - Kirghizistan 2
KR - Corea 2
LK - Sri Lanka 2
MA - Marocco 2
NO - Norvegia 2
PA - Panama 2
RO - Romania 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BY - Bielorussia 1
HU - Ungheria 1
IM - Isola di Man 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.439
Salva come PNG Salva come JPEG
Città #
Dublin 770
Chandler 439
Jacksonville 377
Abidjan 270
Vienna 191
Helsinki 156
Ann Arbor 117
Singapore 111
Wilmington 106
San Mateo 78
Princeton 61
Hong Kong 57
Warsaw 53
Houston 52
Rome 52
Woodbridge 50
Boardman 43
Dearborn 42
Los Angeles 35
New York 31
Brussels 30
Ashburn 29
Beijing 29
Dallas 24
London 22
Molise 20
Redwood City 20
Frankfurt am Main 19
Toronto 16
Council Bluffs 14
Jinan 14
Milan 14
Moscow 12
Ottawa 12
Mountain View 11
Falkenstein 10
Amsterdam 9
Guangzhou 9
Nanjing 9
Manchester 8
Borås 7
Esslingen am Neckar 7
Leawood 7
Rochester 7
Shanghai 7
Shenyang 7
The Dalles 7
Ardabil 6
Augusta 6
Haikou 6
Ningbo 6
Rockville 6
Zhengzhou 6
Changsha 5
Chennai 5
Falls Church 5
Newark 5
Seattle 5
São Paulo 5
Taiyuan 5
Fleet 4
Hefei 4
Paola 4
Tianjin 4
Ariccia 3
Bangkok 3
Chicago 3
Ilmenau 3
Lappeenranta 3
Mexico City 3
Monmouth Junction 3
Norwalk 3
Palermo 3
Riga 3
Simi Valley 3
Sofia 3
Taizhou 3
Tokyo 3
Turin 3
Assago 2
Auburn Hills 2
Avignon 2
Bari 2
Bishkek 2
Bologna 2
Cagliari 2
Cairo 2
Campi Bisenzio 2
Cernusco sul Naviglio 2
Chengdu 2
Chiaravalle Centrale 2
Chongqing 2
Colombo 2
Eden Prairie 2
Fairfield 2
Florence 2
Forlì 2
Ho Chi Minh City 2
Impruneta 2
Jaipur 2
Totale 3.645
Salva come PNG Salva come JPEG
Nome #
Spondiloartriti assiali: dalla patogenesi della neoformazione ossea alla valutazione di possibili biomarcatori di attività di malattia e remissione clinica 243
An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment 133
Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting 115
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. 112
Validity, responsiveness and feasibility of an Italian version of the Canadian Occupational Performance Measure for patients with ankylosing spondylitis 104
Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors 102
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients 101
Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis 98
Incidence of rheumatoid arthritis, psoriatic arthritis and polymyalgia rheumatica in an inland area of central Italy: results of the CAMPO-RHE study 97
Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients 95
Chronic periaortitis with retroperitoneal fibrosis successfully treated with first line tocilizumab monotherapy: a case report 94
Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate 91
Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study 91
Unmet Needs in Axial Spondyloarthritis 90
Assessment of subclinical atherosclerosis in ankylosing spondylitis: Correlations with disease activity indices 89
Comparison of composite indices tailored for psoriatic arthritis treated with csDMARD and bDMARD: A cross-sectional analysis of a longitudinal cohort 89
From clinical remission to residual disease activity in spondyloarthritis and its potential treatment implications 89
Secukinumab for ankylosing spondylitis and psoriatic arthritis 88
The role of IL-17 in the treatment of psoriatic arthritis 87
An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings 87
Mesenchimal stem cells: A possible role in the pathogenesis and treatment of spondyloarthritis 86
An overview of low disease activity and remission in psoriatic arthritis. 85
Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs 85
Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis 84
Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis 84
Defining low disease activity states in psoriatic arthritis using novel composite disease instruments 83
Predictors of loss of remission and disease flares in patients with axial spondyloarthritis receiving antitumor necrosis factor treatment: A retrospective study 81
Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study 80
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs 79
Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study. 78
Subcutaneous anti-TNF alfa induced sustained minimal disease activity and remission in psoriatic arthritis patients: a retrospective study 76
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: Association with disease activity and quality of life indices 76
Multimorbidity and comorbidity in psoriatic arthritis–a perspective 76
Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis. 73
Patient's global assessment as an outcome measure for psoriatic arthritis in clinical practice: A surrogate for measuring low disease activity? 73
Role of comorbidities in spondyloarthritis including psoriatic arthritis 71
New approved drugs for psoriatic arthritis. 70
Psoriatic arthritis: is it time to treat-to-target or target to treat? 69
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 69
The sex influence on response to tumor necrosis factor-α inhibitors and remission in axial spondyloarthritis 68
Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study 67
Effectiveness of adalimumab for the treatment of psoriatic arthritis: An Italian real-life retrospective study 64
Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab 62
Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis 61
Dr. Lubrano, et al reply 61
Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study 60
Assessment of widespread and extra-articular pain in psoriatic arthritis: a case-control study 60
Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? 58
To move or not to move: The paradoxical effect of physical exercise in axial spondyloarthritis 58
Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Patients with Psoriatic Arthritis, Psoriasis, and Fibromyalgia Syndrome: The ULISSE Study 57
Impact of physical activity on disability risk in elderly patients hospitalized for mild acute diverticulitis and diverticular bleeding undergone conservative management 57
Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study 56
TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis 55
Occult axial involvement in patients with psoriatic arthritis mutilans: a case report 54
Clinical and imaging assessment of peripheral enthesitis in Ankylosing Spondylitis 52
New Insights in Physical Therapy and Rehabilitation in Axial Spondyloarthritis: A Review 50
Residual disease activity and associated factors in Psoriatic Arthritis 50
Power Doppler ultrasonographic evaluation of enthesitis in psoriatic arthritis. A multi-center study 47
Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study 45
Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study 44
Clinical Characteristics of Potential "Difficult-to-treat" Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 44
Rheumatology Care in the Face of COVID-19 44
The "Climb" Towards Minimal Disease Activity in Psoriatic Arthritis 37
SARS-CoV-2 IgM False-Positivity in a Psoriatic Arthritis Patient Seropositive for Rheumatoid Factor and ACPA: An Interference of Immune Response? 36
The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity 35
MRI Assessment of Extra-axial Findings at Pelvic Sites in a Group of Axial-SpA Patients 34
Psoriatic Arthritis in Males and Females: Differences and Similarities 33
Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations 32
Constrictive Pericarditis With Massive Calcification in Systemic Sclerosis Treated With Pericardiectomy: A Case Report 32
Valutazione ecografica del tendine di Achille e dell'entesi rotulea nei giocatori di calcio e basket: potrebbe essere utile per prevedere lo sviluppo di lesioni muscolari e tendinee? 30
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review 30
Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective 27
Therapeutic Targets for Ankylosing Spondylitis - Recent Insights and Future Prospects 26
Assessment of Patient-Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study 25
Ultrasonographic Evaluation of Entheseal Fibrocartilage in Patients with Psoriatic Arthritis, Athletes and Healthy Controls: A Comparison Study 25
Livelli aumentati di IL19 nel liquido sinoviale di pazienti con artrite psoriasica 25
Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk 24
Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician 24
Valutazione dei fattori predittivi per il raggiungimento della remissione parziale (RP) secondo i criteri ASAS nei pazienti con Spondilite Anchilosante (SA) trattati con farmaci antagonisti del TNF 23
Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study 22
Patient reported outcomes in early vs late diagnosis of psoriatic arthritis|Resultados informados por los pacientes en el diagnóstico precoz respecto a los pacientes con diagnóstico tardío en la artritis psoriásica 21
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis 19
Difficult-to-treat concept in Psoriatic Arthritis: analysis of two potential definitions in a large group of patients. A cross-sectional study 19
Clinical Characteristics of "Severe" Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 18
Triple jump for the optimal management of psoriatic arthritis: Diet, sleep and exercise - A review 18
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 16
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis 15
VALUTAZIONE DELLA REMISSIONE CLINICA SECONDO I CRITERI ASAS NEI PAZIENTI CON SPONDILOARTRITE ASSIALE TRATTATI CON FARMACI BIOLOGICI ANTAGONISTI DEL TNF ALPHA: STUDIO RETROSPETTIVO MULTICENTRICO 15
Elevated levels of IL-19 in the joints of patients with psoriatic arthritis 15
Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts 13
Two sides of management recommendations for psoriatic arthritis 13
Male Fertility in Spondyloarthritis: from Clinical Issues to Cytokines Milieu. A Narrative Review 13
Sex-related differences in psoriatic arthritis 11
Psoriatic Arthritis Acceptable Symptoms State: Does Sex Make a Difference? 8
Visceral muscle dysmotility syndrome in systemic lupus erythematosus: which is the role of 18 fluorodeoxyglucose-positron emission tomography-computed tomography? A clinical case and literature review 6
Assessment of Carpal Tunnel Syndrome in Patients With Wrist Involvement During the Course of Inflammatory Arthritis. A Cross-Sectional Study 4
Ultrasound description of cortical-entheseal bone remodeling in peripheral entheses of patients with psoriasis and nonspecific musculoskeletal symptoms 4
Long-Term Survival of Methotrexate as First-Line Therapy in Rheumatoid Arthritis, Psoriatic Arthritis and Undifferentiated Arthritis 3
Totale 5.598
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.627
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020112 0 0 0 0 0 0 0 0 0 44 12 56
2020/2021582 20 57 4 83 103 28 76 12 76 15 99 9
2021/2022359 15 76 16 17 17 7 10 38 49 71 14 29
2022/20231.805 218 74 34 151 68 126 15 86 895 67 39 32
2023/2024473 132 68 34 19 23 51 2 33 17 23 19 52
2024/20251.249 319 69 193 21 285 36 21 96 163 46 0 0
Totale 5.598